Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.25 (-0.89%)
At close: Dec 31, 2025
Genovate Biotechnology Company Description
Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan.
It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics.
The company was founded in 1982 and is based in Hsinchu City, Taiwan.
Genovate Biotechnology Co., Ltd.
| Country | Taiwan |
| Founded | 1982 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 195 |
| CEO | Chia-Chen Chu |
Contact Details
Address: No. 1, Gongye 1st Road Hsinchu City, 30351 Taiwan | |
| Phone | 886 3 598 2221 |
| Website | genovate-bio.com |
Stock Details
| Ticker Symbol | 4130 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004130000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jen Chen Ph.D. | Chairman and Chief Strategy Officer |
| Chia-Chen Chu | GM and Director |
| Hui-Ling Lin | Deputy GM of Finance and Accounting Supervisor |
| Wei-Min Chiang | Senior Director of Administration Division |